Hikma pharmaceuticals stock
WebThe Hikma Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention. WebApr 12, 2024 · Hikma Pharmaceuticals PLC announces that Riad Mishlawi, President of the Group's Injectables business, has been appointed Chief Executive Officer (CEO), effective 1 September 2024. Thereafter, Said Darwazah will step down as acting CEO and return to his role as Executive Chairman. As CEO, Riad will bring his deep knowledge of Hikma and the ...
Hikma pharmaceuticals stock
Did you know?
WebApr 12, 2024 · The London-based pharmaceutical company said it promoted Mishlawi from his current role as president of the group's Injectables business since 2011, and will bring his "deep knowledge of Hikma and the pharmaceutical industry", alongside a "strong track record" of delivering profitable growth and strategic expansion. WebApr 12, 2024 · About Hikma Pharmaceuticals (OTCMKTS:HKMPY) Stock Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others.
WebView Hikma Pharmaceuticals Plc HKMPF investment & stock information. Get the latest Hikma Pharmaceuticals Plc HKMPF detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. WebApr 13, 2024 · Hikma Pharmaceuticals Stock Up 1.6 %. Shares of HIK opened at GBX 1,804.50 ($22.35) on Wednesday. The firm has a market cap of £3.98 billion, a P/E ratio of 2,651.49, a P/E/G ratio of 2.38 and a ...
WebApr 12, 2024 · Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms in North America, the Middle East, North Africa, and Europe. WebHIKMA PHARMACEUTICALS PLC HIK Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals London Stock Exchange uses cookies to improve its website.
WebApr 12, 2024 · As of last trade, Hikma Pharmaceuticals PLC (HIK:LSE) traded at 1,650.00, 40.49% above the 52 week low of 1,174.50 set on Oct 24, 2024. 52-week range Today 1,174.50 Oct 24 2024 2,137.00 Mar 25...
WebJul 15, 2024 · Is Hikma Pharmaceuticals PLC's (LON:HIK) Recent Stock Performance Influenced By Its Fundamentals In Any Way? Hikma Pharmaceuticals (LON:HIK) has had a great run on the share market with its stock up by a significant 15% over the... Feb 27, 2024 news.yahoo.com Hikma Pharmaceuticals PLC (HKMPF) Q4 2024 Earnings Call Transcript how many people have claustrophobiaWebApr 6, 2024 · Hikma Pharmaceuticals - HKMPF News Today $20.27 -0.37 (-1.79%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $20.27 $20.27 50-Day Range $18.87 $21.36 52-Week Range $13.76 $28.00 Volume 90 shs Average Volume 237 shs Market Capitalization $4.46 billion P/E Ratio N/A Dividend Yield 3.65% Price Target N/A Profile … how can i tour the pentagonWebJun 25, 2024 · Hikma Pharmaceuticals Plc primarily trades on the London Stock Exchange. It has a U.S listing, but its liquidity seems quite poor. It adopts IFRS accounting standards for its earnings... how can i tighten my neck skinhow many people have claimed to be jesusWebHikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the launch of four new sterile injectable medicines in Canada, providing important new treatment... how many people have chuuya killedWebHikma Pharmaceuticals (GB:HIK) shares started a downward trend after it reported its interim results for 2024 on August 4 - but the stock might offer a decent option for longer-term investors. The ... how many people have claimed to be godWebInvestments 21 Share Price $21.00 (As of Friday Closing) General Information Description Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. how many people have climbed mount mckinley